Stratagene to Pay Third Wave $10.75M to Settle Wisconsin Case, Seeks Stay in Other Litigation | GenomeWeb
This story originally appeared in Biocommerce Week, a newsletter that has been discontinued.
 
Stratagene and Third Wave have reached a $10.75 million settlement in one of the cases between the firms, which had been decided in Third Wave’s favor by a Wisconsin jury.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.